We focus on publicly traded healthcare companies whose technologies and service models have the potential to improve healthcare delivery, expand access, and lower the cost of care. Our process combines fundamental company research, evaluation of clinical and commercial trajectories, and an understanding of how healthcare solutions are adopted, reimbursed, and scaled.

Alongside this fundamental work, we apply a quantitative framework that ranks companies across measures of value, quality, and growth. The framework helps us identify candidates worth deeper diligence and provides a disciplined check on positioning decisions across the portfolio.

We take a long-term view, believing that the most meaningful value creation comes from compounding business performance over years, not quarters.